<DOC>
	<DOC>NCT02352090</DOC>
	<brief_summary>The main objective of the study is to compare the metabolic effects of natural estradiol and synthetic ethinylestradiol used in combined oral contraception in healthy women. A progestin-only preparation will be used in comparison. The main goal is to study the effects on glucose metabolism, coagulation and a markers of chronic inflammation (such as hs-CRP). Our hypothesis is that the natural estradiol preparation will influence blood glucose levels, markers of coagulation and chronic inflammation less than the ethinylestradiol preparation. The progestin-only preparation will not effect these parameters.</brief_summary>
	<brief_title>Synthetic vs Natural Estrogen in Combined Oral Contraception</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Nandrolone</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Progestins</mesh_term>
	<criteria>BMI 1924.9, regular menstrual cycles (2135 days), a minimum of 2 months without any hormonal contraceptives, no contraindications for use of hormonal contraception Polycystic ovaries, hypertension, smoking, alcohol abuse, pregnancy, lactation, abnormal result in prescreening 2h oral glucose tolerance test, regular medications</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Contraception, oral</keyword>
	<keyword>Ethinyl Estradiol</keyword>
	<keyword>Estradiol Valerate</keyword>
	<keyword>Dienogest</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Chronic inflammation</keyword>
	<keyword>Coagulation</keyword>
</DOC>